AU Patent

AU2024345848A1 — Pharmaceutical composition containing heteroaryl oxynaphthalene compound, preparation method therefor, and use thereof

Assigned to Shanghai Runshi Medical Technology Co Ltd · Expires 2026-04-09 · 0y expired

What this patent protects

The invention relates to a pharmaceutical composition containing a compound (A), a preparation method therefor, and a use thereof. The preparation method for the pharmaceutical composition is simple and suitable for industrial large-scale production, and tablets prepared from the…

USPTO Abstract

The invention relates to a pharmaceutical composition containing a compound (A), a preparation method therefor, and a use thereof. The preparation method for the pharmaceutical composition is simple and suitable for industrial large-scale production, and tablets prepared from the pharmaceutical composition have good active ingredient content uniformity and a good active ingredient dissolution rate, have stable properties, and are suitable for long-term storage.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024345848A1
Jurisdiction
AU
Classification
Expires
2026-04-09
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Runshi Medical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.